Estrogen, male dominance and esophageal adenocarcinoma: is there a link?

World J Gastroenterol. 2012 Feb 7;18(5):393-400. doi: 10.3748/wjg.v18.i5.393.

Abstract

Esophageal adenocarcinoma is a cancer with poor prognosis, and its incidence has risen sharply over recent decades. Obesity is a major risk factor for developing this cancer and there is a clear male gender bias in the incidence that cannot be fully explained by known risk factors. It is possible that a difference in the expression of estrogen, or its signaling axes, may contribute to this gender bias. We undertook a comprehensive literature search and analyzed the available data regarding estrogen and estrogen receptor expression, and the possible sex-specific links with esophageal adenocarcinoma development. Potentially relevant associations between visceral vs subcutaneous fat deposition and estrogen expression, and the effect of crosstalk between estrogen and leptin signaling were identified. We also found limited studies suggesting a role for estrogen receptor β expression in esophageal adenocarcinoma development. The current literature supports speculation on an etiological role for estrogen in the male gender bias in esophageal adenocarcinoma, but further studies are required.

Keywords: Esophageal adenocarcinoma; Estrogen; Estrogen receptors; Male dominance.

Publication types

  • Editorial
  • Review

MeSH terms

  • Adenocarcinoma / epidemiology
  • Adenocarcinoma / metabolism*
  • Adenocarcinoma / pathology
  • Adipose Tissue / anatomy & histology
  • Adipose Tissue / metabolism
  • Esophageal Neoplasms / epidemiology
  • Esophageal Neoplasms / metabolism*
  • Esophageal Neoplasms / pathology
  • Estrogen Receptor alpha / metabolism
  • Estrogen Receptor beta / metabolism
  • Estrogens / metabolism*
  • Female
  • Humans
  • Leptin / metabolism
  • Male
  • Sex Factors
  • Signal Transduction / physiology

Substances

  • ESR1 protein, human
  • Estrogen Receptor alpha
  • Estrogen Receptor beta
  • Estrogens
  • Leptin